Sourcing comparator and reference listed drug products for clinical trials can be complex, expensive, and highly time-sensitive. In some cases, traditional procurement channels may even risk exposing confidential development programs. Specialty PharmaSource simplifies this process through experience, discretion, and a deeply established global sourcing network.
As a fully licensed pharmaceutical wholesale distributor operating under DEA, DSCSA, GDP, and GCP-compliant frameworks, we procure branded Innovator Samples and Reference Listed Drugs (RLDs) to support bioequivalence studies, clinical trials, and regulatory submissions worldwide. We source single or multiple batches in precise quantities, including hard-to-find, allocation-controlled, specialty, REMS-restricted, drug shortage, and unlicensed medicines.
Our team manages end-to-end cold chain logistics and international customs coordination to ensure temperature-sensitive and high-value study drugs arrive at clinical sites in full compliance with required storage and handling conditions. We provide proactive guidance on specialty products, manufacturer allocations, potential shortages, and supply risk mitigation strategies—helping you maintain trial timelines and protect program integrity.
A quiet truth about comparator sourcing: the real risk is rarely just price. Delays, allocation constraints, and documentation gaps can derail months of development. Precision logistics in clinical supply requires managing uncertainty with discipline rather than simply moving products. Specialty PharmaSource ensures reliable outcomes through expertise, proactive planning, and a globally established sourcing network.
Contact us to learn more.